Skip to content
Hexagon Bio logo — Discovering novel medicines in the global metagenome and bri...

Hexagon Bio

Discovering novel medicines in the global metagenome and bringing them to patients

Founded 2016 United States Menlo Park, United States 75 employees Series B Total: $193.60M Biotechnology, Health Care +1

General Information

Company Name Hexagon Bio
Founded Year 2016
Location United States Menlo Park, United States
Employees 75
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Hexagon Bio. To contact Hexagon Bio, visit hexagonbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hexagon Bio compare?

A PDF of Hexagon Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hexagon Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hexagon Bio

Hexagon Bio is a biopharma company founded in 2016 and based in the United States. The company is focused on discovering novel medicines in the global metagenome and bringing them to patients. Utilizing a data-driven approach, Hexagon Bio develops targeted small molecule therapeutics by integrating data science, genomics, synthetic biology, chemistry, and automation. Their proprietary platform enables the discovery of potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences.

With a specific emphasis on mining fungal genomes, Hexagon Bio is dedicated to inspiring the next generation of targeted therapies for diseases with unmet needs. In their most recent funding round in October 2022, the company secured a substantial $77.30M Series B investment. The investors in this round included Two Sigma Ventures, 8VC, The Column Group, ATEL Capital, Nextech Invest, and Canada Pension Plan Investment Board.

The innovative and multi-disciplinary approach of Hexagon Bio positions it at the forefront of biotechnology and healthcare industries, offering promising potential for addressing unmet medical needs and advancing the discovery of transformative medicines.

Business keywords: biopharma, data-driven, genomics, synthetic biology, chemistry, small molecule therapeutics, DNA sequences, fungal genomes, targeted therapies, unmet needs

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $77.30M 6
Two Sigma Ventures, 8VC +4
11 Oct 2022
Venture Round $61.00M 4
Two Sigma Ventures, Casdin Capital +2
22 Sep 2021
Series A $47.00M -
15 Sep 2020
Seed Round $8.30M -
01 Jun 2017

Hexagon Bio Alternatives & Competitors

View All Alternatives
Hexagon Bio vs

Precision Science Inspired by Human Biology

Acquired
271 employees
Biotechnology, Health Care
Hexagon Bio vs

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
Hexagon Bio vs

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

Series D
Biopharma, Biotechnology

FAQ About Hexagon Bio

Discovering novel medicines in the global metagenome and bringing them to patients
Hexagon Bio was founded in 2016.
Hexagon Bio is headquartered in Menlo Park, United States.
Hexagon Bio operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biopharma, data-driven, genomics and synthetic biology.
Hexagon Bio has approximately 75 employees.
Hexagon Bio has completed 4 funding rounds, raising a total of $193.60M. The latest funding stage is Series B.
Top alternatives and competitors to Hexagon Bio include Vividion Therapeutics, Inc., Synnovation Therapeutics, Myogen, IDEAYA Biosciences, Tavros Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hexagon Bio and Vividion Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hexagon Bio, https://bouncewatch.com/company/hexagon-bio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout